Tectonic Therapeutic, Inc.
TECXNasdaqCIK 1681087HealthcareFiscal year ends Dec 31
Reports and events: 171 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2917:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-407823 |
| 2026-08-0616:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338062 |
| 2026-08-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338000 |
| 2026-06-1017:08 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-266040 |
| 2026-05-0716:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-212069 |
| 2026-05-0716:19 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212016 |
| 2026-04-2416:39 ET | DEF 14A | Proxy statementPeriod 2026-06-08 | 0001193125-26-177467 |
| 2026-04-2316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-173829 |
| 2026-02-2616:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076843 |
| 2026-02-2616:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076793 |
| 2026-02-2416:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-066964 |
| 2025-11-0616:28 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269701 |
| 2025-11-0616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269573 |
| 2025-10-3019:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-256958 |
| 2025-08-0717:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-175567 |
| 2025-08-0716:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104974 |
| 2025-06-0616:48 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-137149 |
| 2025-05-1916:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-122511 |
| 2025-05-0816:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067037 |
| 2025-05-0816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066932 |
| 2025-04-2516:09 ET | DEF 14A | Proxy statementPeriod 2025-06-06 | 0001193125-25-096764 |
| 2025-04-0719:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-029553 |
| 2025-04-0717:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-051678 |
| 2025-04-0716:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-051604 |
| 2025-03-2617:09 ET | S-1 | Registration statement | 0001193125-25-064163 |
| 2025-03-2016:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-042648 |
| 2025-03-2016:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042630 |
| 2025-02-1006:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-011462 |
| 2025-02-0717:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-016480 |
| 2025-02-0716:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-016399 |
| 2025-02-0306:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-018840 |
| 2025-01-3006:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-016224 |
| 2025-01-1316:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005304 |
| 2024-11-1216:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125304 |
| 2024-11-0716:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123411 |
| 2024-10-2818:08 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-111899 |
| 2024-10-2417:12 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-090440 |
| 2024-09-2620:41 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-082376 |
| 2024-09-1917:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-222189 |
| 2024-08-1416:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-200629 |
| 2024-08-1416:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001193125-24-200609 |
| 2024-07-3016:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-188881 |
| 2024-07-1916:02 ET | S-1 | Registration statement | 0001193125-24-181624 |
| 2024-07-0516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-175599 |
| 2024-06-2716:27 ET | SC 13D | Ownership report, active investor | 0001104659-24-075687 |
| 2024-06-2608:00 ET | SC 13D | Ownership report, active investor | 0001213900-24-055917 |
| 2024-06-2621:52 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-168273 |
| 2024-06-2516:23 ET | SC 13D | Ownership report, active investor | 0001193125-24-167893 |
| 2024-06-2016:25 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-164480 |
| 2024-06-1811:51 ET | 8-K/A | 8.01 Other events | 0001193125-24-163207 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 10:58 ET. Listed shows no prices and gives no investment advice.